Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M. Drummond.
Time for a change in drug licensing requirements?.
Eur J Health Econ, 3 (2002), pp. 137-138
[2.]
A. Maynard.
Towards a Euro-NICE?.
Eurohealth, 7 (2001), pp. 26
[3.]
S.D. Pearson, M.D. Rawlins.
Quality, innovation, and value for money, NICE and the British National Health Service.
JAMA, 294 (2005), pp. 2618-2622
[4.]
A. Williams.
What could be NICER than NICE? OHE Annual Lecture.
The Office of Health Economics, (2004),
[5.]
Costas E. Un «déja vu» donde las cuentas dista de favorecer al comprador. El País, 25 de mayo de 2006; p. 62.
Copyright © 2007. Sociedad Española de Salud Pública y Administración Sanitaria
